secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001193125-23-278946
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma files prospectus for 383,000 shares under equity incentive plan
------------------------------------------------------------------------------

- Prospectus supplement covers up to 383,000 Class A ordinary shares.
- Shares to be awarded to employees and consultants of RP Management LLC.
- Awards granted under the RP Management Equity Incentive Plan.
- Legal opinion from Davis Polk & Wardwell filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312523278946/0001193125-23-278946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312523278946/d576980d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-278946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer